2022
DOI: 10.1096/fasebj.2022.36.s1.r2721
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological Evaluation of Beta‐Hydroxifosphocarnitine in No‐Alcoholic Esteatohepatitis Induced in Rats

Abstract: Aim Evaluate the pharmacological effect of Β‐Hydroxyphosphocarnitine (β‐HFC) on non‐alcoholic steatohepatitis induced in rats. Introduction Nonalcoholic steatotepatitis (NASH) is a serious global public health problem, it is related to other pathologies with increasing prevalence, manifested in the increased prevalence of NASH. Type 2 diabetes mellitus and obesity are the main pathologies related to NASH. There is no specific drug for NASH, the current drugs used for NASH are related to serious side effects, w… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles